Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.
about
Chromogenic in situ hybridization (CISH): a novel alternative in screening archival breast cancer tissue samples for HER-2/neu statusRelative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplificationPolysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situ hybridization and immunohistochemistry.Investigation of three new mouse mammary tumor cell lines as models for transforming growth factor (TGF)-beta and Neu pathway signaling studies: identification of a novel model for TGF-beta-induced epithelial-to-mesenchymal transitionImmunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in breast carcinoma in JordanTargeted therapies with companion diagnostics in the management of breast cancer: current perspectivesPotential therapeutic implications of IL-6/IL-6R/gp130-targeting agents in breast cancerThe fate of chemoresistance in triple negative breast cancer (TNBC)Analysis of different HER-2 mutations in breast cancer progression and drug resistanceModulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1Concomitant oncoprotein detection with fluorescence in situ hybridization (CODFISH): a fluorescence-based assay enabling simultaneous visualization of gene amplification and encoded protein expression.Gold-facilitated in situ hybridization: a bright-field autometallographic alternative to fluorescence in situ hybridization for detection of Her-2/neu gene amplification.Multi-factor data normalization enables the detection of copy number aberrations in amplicon sequencing data.Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction.Chromogenic in situ hybridization: a practical alternative for fluorescence in situ hybridization to detect HER-2/neu oncogene amplification in archival breast cancer samples.LED-FISH: Fluorescence microscopy based on light emitting diodes for the molecular analysis of Her-2/neu oncogene amplification.Her2 assessment using quantitative reverse transcriptase polymerase chain reaction reliably identifies Her2 overexpression without amplification in breast cancer cases.Absence of CCND1 gene amplification in breast tumours of BRCA1 mutation carriers.Low Level of Her-2 Locus Amplification by Fluorescent In Situ Hybridization Does Not Correlate with Her-2 Protein Overexpression by Immunohistochemistry in Barrett's Esophagus.Testing for HER2 in Breast Cancer: A Continuing Evolution.Primary human ovarian epithelial cancer cells broadly express HER2 at immunologically-detectable levels.The molecular genomics of metastatic brain tumours.Screening and Molecular Analysis of Single Circulating Tumor Cells Using Micromagnet Array.Determination of the differential expression of mitochondrial long non-coding RNAs as a noninvasive diagnosis of bladder cancerEvaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic CoImmunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches.Evaluation of intratumoral HER-2 heterogeneity by fluorescence in situ hybridization in invasive breast cancer: a single institution studyEfficacy of TCH/TEC neoadjuvant chemotherapy for the treatment of HER-2-overexpressing breast cancer.Breast cancer biology and ethnic disparities in breast cancer mortality in new zealand: a cohort study.HER2/neu Immunostaining in Invasive Breast Cancer: Analysis of False Positive Factors.The pathology of hereditary breast cancer.Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assaysIHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.Allelic imbalance at the HER2/TOP2A locus in breast cancerAmplification of the c-erbB-2 (HER-2/neu) gene in gastric cancer cells. Detection by fluorescence in situ hybridizationAmplification and deletion of topoisomerase IIalpha associate with ErbB-2 amplification and affect sensitivity to topoisomerase II inhibitor doxorubicin in breast cancer.Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.Stage of breast cancer at diagnosis in New Zealand: impacts of socio-demographic factors, breast cancer screening and biology.Amplification of the HER2 gene in breast cancers testing 2+ weak positive by HercepTest immunohistochemistry: false-positive or false-negative immunohistochemistry?
P2860
Q21195160-DFD9F090-3465-4641-BC70-F54B98DD5D72Q24530153-F960D8D7-AC79-4A83-9761-C71313D00A8BQ24797806-14D7985B-9D01-4FA7-AA49-A1310130ACEDQ24806331-3154B4A0-E8A6-43A1-8E10-5910756A7DFFQ24813346-A206400D-4B00-4FEE-9576-0C81CEEAEFA9Q26768119-08EC1A28-C7A5-4998-9689-5217886F3F79Q26769917-16C5E7D6-1DE7-4DA5-BF5E-2EE4A46DEFF0Q26775232-18E5A511-487F-487D-BDC8-6662F2FB54B1Q26797471-C98713A0-04E0-4132-B5B8-8B8BD37371CBQ28655621-FAABB6C1-BA61-4417-BB80-A1BEC1EF6888Q30444672-62AA99A7-6725-4D9B-B380-3E4D28214C37Q30444859-C06F10A2-DB9D-4F55-8A5C-2B0544657D39Q30836209-AE7E1AA9-73AA-4395-BE38-5BB5B2100249Q30856729-C5193E76-C74A-4A3D-A56A-E4A60E799303Q30879242-5F1612C3-6573-4852-8EEB-B71FBFBCF252Q30959521-4C40D94A-A202-4C65-ACFF-502B972DD922Q33393408-07FAE112-332F-4BDB-BCC2-54A5DAA38DCBQ33623561-75937BDF-AA6E-4AFB-BF97-BFBDB5D87621Q33918764-1D54F258-2869-4ABD-B4A8-DE244AA022D8Q33984756-983754CE-AB83-44B4-9061-D48FCADCC5E6Q34424285-0C947483-2EDD-4594-B82B-4676FF690CA6Q34493886-6457E7C3-1C36-49B2-9515-D445FF394ECDQ34499855-D13F50EE-3273-47F9-BC59-B33EC40E9803Q34500586-167E4220-1336-4BE3-829B-BA6EDA9A62E7Q34515117-AF409B7F-C913-414A-A02A-4C7CA5292458Q34640536-0C05E9CC-D56C-4F5F-9434-D85480D83DD0Q35034555-836CF7DB-1606-40FD-9F9B-9EF41BC9DEEEQ35158754-22090BD1-E168-48D7-BEBA-510E880B09A3Q35167644-98BBCD06-8DF2-4148-84E0-FE5507E23E66Q35300442-CF4721C3-B337-49F8-9D20-37145FB0570EQ35323892-9970AFD7-E156-4C9A-A42B-DC4C9DC51E23Q35355084-209C6C5D-2C41-4E3F-AAA8-E0FBDB7AEB5DQ35396369-C2BEE5E1-4BBA-45F1-8F59-FABCFE3BB6CFQ35588768-8E855C1A-4F2E-47AF-8039-CC54EE8790E2Q35663036-CB4ADF5F-517F-408E-813C-6D9829FC0904Q35763518-5C608301-854C-4D47-B6A5-C44DCDB4379BQ35809752-F8A5B2C2-1465-4FD2-BB20-74BF4AC7E7BAQ35835151-0F4591A0-281B-4011-AFEB-2E82A23E7707Q35929078-6EC7CD37-C46D-42B1-9885-2B7CA51E4871Q35954388-2E656E7F-1DC7-433B-B6EF-9829C3145677
P2860
Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Detection and quantitation of ...... escence in situ hybridization.
@en
type
label
Detection and quantitation of ...... escence in situ hybridization.
@en
prefLabel
Detection and quantitation of ...... escence in situ hybridization.
@en
P2093
P1433
P1476
Detection and quantitation of ...... escence in situ hybridization.
@en
P2093
P407
P577
1996-07-01T00:00:00Z